{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T20:02:43Z","timestamp":1794600163533,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The present study reports the functional and anatomical outcomes of eyes with acute retinal necrosis(ARN).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective case series conducted at a tertiary Eye Hospital from March 2015 to March 2020. Medical records of patients with clinical and laboratorial\u2014Polymerase Chain Reaction (PCR)\u2014diagnosis of ARN were reviewed. To identify factors related to the outcomes of visual acuity(VA) and retinal detachment (RD) over time, Cox proportional hazards regression modeling and survival analyses were used.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-three eyes of 23 patients (16 male, 7 female) were reviewed. Based on the PCR results, 16 cases (69.6%) had Varicella zoster virus, 3 cases (13%) had Cytomegalovirus, 1 patient (4.3%) had Herpes simplex virus associated ARN, and 1 case (4.3%) had negative PCR. The incident rate for \u2265\u20092-line VA gain was 0.28\/eye-year (EY) (95% CI 0.21\u2009\u00b1\u20090.26) while the rate of severe vision loss was 0.09\/eye-year (95% CI 0.05\u2009\u00b1\u20090.08). The RD development was observed at a rate of 0.43\/eye-year (0.42\u2009\u00b1\u20090.02), which occurred in 9 eyes with a mean time of 100\u00a0days after the initial presentation of ARN. Patients\u2019 age was the only factor associated with 2-line or more gain in VA over time with a hazard ratio of 0.921 (95% CI 0.854\u20130.993, P\u2009=\u20090.032).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Generally, although being crucial,\u00a0treatment is not highly effective in improvement of VA and decrease of RD development, as well as vision loss, in patients with ARN. However, treatment prevents fellow eye involvement efficiently. Younger age is associated with better response to treatment and more chance to achieve better VA.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-022-00417-w","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T11:04:20Z","timestamp":1663239860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Acute retinal necrosis. Management and visual outcomes: a case series"],"prefix":"10.1186","volume":"8","author":[{"given":"Alireza","family":"Mojarrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Omidtabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Ansari Astaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Bakhtiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Shiezadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Hassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Maryam","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"417_CR1","first-page":"607","volume":"25","author":"AYN Urayama","year":"1971","unstructured":"Urayama AYN, Sasaki T. Unilateral acute uveitis with periarteritis and detachment. Japanies J Ophthalmol. 1971;25:607\u201319.","journal-title":"Japanies J Ophthalmol"},{"issue":"12","key":"417_CR2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/s0161-6420(82)34638-2","volume":"89","author":"WW Culbertson","year":"1982","unstructured":"Culbertson WW, Blumenkranz MS, Haines H, et al. The acute retinal necrosis syndrome. Part 2: Histopathology and etiology. Ophthalmology. 1982;89(12):1317\u201325. https:\/\/doi.org\/10.1016\/s0161-6420(82)34638-2.","journal-title":"Ophthalmology"},{"issue":"2","key":"417_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/s0002-9394(99)00316-5","volume":"129","author":"JB Ganatra","year":"2000","unstructured":"Ganatra JB, Chandler D, Santos C, et al. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol. 2000;129(2):166\u201372. https:\/\/doi.org\/10.1016\/s0002-9394(99)00316-5.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"417_CR4","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.ophtha.2009.03.029","volume":"116","author":"J Hillenkamp","year":"2009","unstructured":"Hillenkamp J, N\u00f6lle B, Bruns C, et al. Acute retinal necrosis: clinical features, early vitrectomy, and outcomes. Ophthalmology. 2009;116(10):1971-5.e2. https:\/\/doi.org\/10.1016\/j.ophtha.2009.03.029.","journal-title":"Ophthalmology"},{"issue":"11","key":"417_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1136\/bjo.2007.114884","volume":"91","author":"MN Muthiah","year":"2007","unstructured":"Muthiah MN, Michaelides M, Child CS, et al. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol. 2007;91(11):1452\u20135. https:\/\/doi.org\/10.1136\/bjo.2007.114884.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"417_CR6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/eye.2011.338","volume":"26","author":"TF Cochrane","year":"2012","unstructured":"Cochrane TF, Silvestri G, McDowell C, et al. Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study. Eye. 2012;26(3):370\u20138. https:\/\/doi.org\/10.1038\/eye.2011.338.","journal-title":"Eye"},{"issue":"5","key":"417_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/s0002-9394(14)70075-3","volume":"117","author":"GN Holland","year":"1994","unstructured":"Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994;117(5):663\u20137. https:\/\/doi.org\/10.1016\/s0002-9394(14)70075-3.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"417_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ophtha.2016.11.007","volume":"124","author":"SD Schoenberger","year":"2017","unstructured":"Schoenberger SD, Kim SJ, Thorne JE, et al. Diagnosis and treatment of acute retinal necrosis: a report by the American Academy of Ophthalmology. Ophthalmology. 2017;124(3):382\u201392. https:\/\/doi.org\/10.1016\/j.ophtha.2016.11.007.","journal-title":"Ophthalmology"},{"issue":"5","key":"417_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/IAE.0b013e3181c7013c","volume":"30","author":"B Meghpara","year":"2010","unstructured":"Meghpara B, Sulkowski G, Kesen MR, et al. Long-term follow-up of acute retinal necrosis. Retina. 2010;30(5):795\u2013800. https:\/\/doi.org\/10.1097\/IAE.0b013e3181c7013c.","journal-title":"Retina"},{"issue":"2","key":"417_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5301\/ejo.5001039","volume":"28","author":"L Ortega-Evangelio","year":"2018","unstructured":"Ortega-Evangelio L, Navarrete-Sanchis J, Williams BK, et al. Aflibercept in the management of acute retinal necrosis syndrome-related macular edema. Eur J Ophthalmol. 2018;28(2):259\u201361. https:\/\/doi.org\/10.5301\/ejo.5001039.","journal-title":"Eur J Ophthalmol"},{"key":"417_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1755-3768.2010.01911.x","volume":"89","author":"M Witmer","year":"2011","unstructured":"Witmer M, Pavan P, Fouraker B, et al. Acute retinal necrosis associated optic neuropathy. Acta Ophthalmol. 2011;89:599\u2013607. https:\/\/doi.org\/10.1111\/j.1755-3768.2010.01911.x.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"417_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/bjophthalmol-2012-301983","volume":"97","author":"RW Wong","year":"2013","unstructured":"Wong RW, Jumper JM, McDonald HR, et al. Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol. 2013;97(5):545\u201352. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-301983.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"417_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/IAE.0000000000002341","volume":"40","author":"B Lei","year":"2020","unstructured":"Lei B, Jiang R, Wang Z, et al. Bilateral acute retinal necrosis: a case series. Retina. 2020;40(1):145\u201353.","journal-title":"Retina"},{"issue":"7","key":"417_CR14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1080\/09273948.2018.1501494","volume":"27","author":"E Miserocchi","year":"2019","unstructured":"Miserocchi E, Iuliano L, Fogliato G, et al. Bilateral acute retinal necrosis: clinical features and outcomes in a multicenter study. Ocul Immunol Inflamm. 2019;27(7):1090\u20138. https:\/\/doi.org\/10.1080\/09273948.2018.1501494.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"417_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ophtha.2006.06.058","volume":"114","author":"A Aizman","year":"2007","unstructured":"Aizman A, Johnson MW, Elner SG. Treatment of acute retinal necrosis syndrome with oral antiviral medications. Ophthalmology. 2007;114(2):307\u201312. https:\/\/doi.org\/10.1016\/j.ophtha.2006.06.058.","journal-title":"Ophthalmology"},{"issue":"3","key":"417_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/s0161-6420(86)33740-0","volume":"93","author":"MS Blumenkranz","year":"1986","unstructured":"Blumenkranz MS, Culbertson WW, Clarkson JG, et al. Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology. 1986;93(3):296\u2013300. https:\/\/doi.org\/10.1016\/s0161-6420(86)33740-0.","journal-title":"Ophthalmology"},{"key":"417_CR17","first-page":"133","volume":"111","author":"CJ Flaxel","year":"2013","unstructured":"Flaxel CJ, Yeh S, Lauer AK. Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2013;111:133\u201344.","journal-title":"Trans Am Ophthalmol Soc."},{"issue":"5","key":"417_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3928\/23258160-20140908-02","volume":"45","author":"S Yeh","year":"2014","unstructured":"Yeh S, Suhler EB, Smith JR, et al. Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome. Ophthalmic Surg Lasers Imaging Retina. 2014;45(5):399\u2013407. https:\/\/doi.org\/10.3928\/23258160-20140908-02.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"9","key":"417_CR19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/bjo.2008.147181","volume":"92","author":"JJ Park","year":"2008","unstructured":"Park JJ, Pavesio C. Prophylactic laser photocoagulation for acute retinal necrosis. Does it raise more questions than answers? Br J Ophthalmol. 2008;92(9):1161\u20132. https:\/\/doi.org\/10.1136\/bjo.2008.147181.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"417_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ophtha.2009.09.001","volume":"117","author":"MD Tibbetts","year":"2010","unstructured":"Tibbetts MD, Shah CP, Young LH, et al. Treatment of acute retinal necrosis. Ophthalmology. 2010;117(4):818\u201324. https:\/\/doi.org\/10.1016\/j.ophtha.2009.09.001.","journal-title":"Ophthalmology"},{"issue":"5","key":"417_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s10384-009-0698-z","volume":"53","author":"T Ishida","year":"2009","unstructured":"Ishida T, Sugamoto Y, Sugita S, et al. Prophylactic vitrectomy for acute retinal necrosis. Jpn J Ophthalmol. 2009;53(5):486\u20139. https:\/\/doi.org\/10.1007\/s10384-009-0698-z.","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"417_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10384-012-0211-y","volume":"57","author":"C Iwahashi-Shima","year":"2013","unstructured":"Iwahashi-Shima C, Azumi A, Ohguro N, et al. Acute retinal necrosis: factors associated with anatomic and visual outcomes. Jpn J Ophthalmol. 2013;57(1):98\u2013103. https:\/\/doi.org\/10.1007\/s10384-012-0211-y.","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"417_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3980\/j.issn.2222-3959.2012.04.15","volume":"5","author":"YH Luo","year":"2012","unstructured":"Luo YH, Duan XC, Chen BH, et al. Efficacy and necessity of prophylactic vitrectomy for acute retinal necrosis syndrome. Int J Ophthalmol. 2012;5(4):482\u20137. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2012.04.15.","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"417_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","volume":"13","author":"JT Holladay","year":"1997","unstructured":"Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13(4):388\u201391.","journal-title":"J Refract Surg"},{"key":"417_CR25","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.2147\/opth.S258488","volume":"14","author":"B Powell","year":"2020","unstructured":"Powell B, Wang D, Llop S, et al. Management strategies of acute retinal necrosis: current perspectives. Clin Ophthalmol. 2020;14:1931\u201343. https:\/\/doi.org\/10.2147\/opth.S258488.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"417_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ophtha.2009.08.003","volume":"117","author":"R Wong","year":"2010","unstructured":"Wong R, Pavesio CE, Laidlaw DA, et al. Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome. Ophthalmology. 2010;117(3):556\u201360. https:\/\/doi.org\/10.1016\/j.ophtha.2009.08.003.","journal-title":"Ophthalmology"},{"issue":"3","key":"417_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.oret.2020.07.012","volume":"5","author":"MR Debiec","year":"2021","unstructured":"Debiec MR, Lindeke-Myers AT, Shantha JG, et al. Outcomes of combination systemic and intravitreal antiviral therapy for acute retinal necrosis. Ophthalmol Retina. 2021;5(3):292\u2013300. https:\/\/doi.org\/10.1016\/j.oret.2020.07.012.","journal-title":"Ophthalmol Retina"},{"key":"417_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ajo.2017.05.006","volume":"179","author":"NJ Butler","year":"2017","unstructured":"Butler NJ, Moradi A, Salek SS, et al. Acute retinal necrosis: presenting characteristics and clinical outcomes in a cohort of polymerase chain reaction-positive patients. Am J Ophthalmol. 2017;179:179\u201389. https:\/\/doi.org\/10.1016\/j.ajo.2017.05.006.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"417_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1120672120936181","volume":"31","author":"AEN Hedayatfar","year":"2021","unstructured":"Hedayatfar AEN, Zarei MAKM, Mahbod M, Asgari S, Sedaghat A. Acute retinal necrosis: clinical manifestation and long-term visual outcomes in a series of polymerase chain reaction\u2013positive patients. Eur J Ophthalmol. 2021;31(4):9.","journal-title":"Eur J Ophthalmol"},{"key":"417_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ajo.2018.02.001","volume":"188","author":"J Baltinas","year":"2018","unstructured":"Baltinas J, Lightman S, Tomkins-Netzer O. Comparing treatment of acute retinal necrosis with either oral valacyclovir or intravenous acyclovir. Am J Ophthalmol. 2018;188:173\u201380. https:\/\/doi.org\/10.1016\/j.ajo.2018.02.001.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"417_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1442-9071.2009.02083.x","volume":"37","author":"JL Sims","year":"2009","unstructured":"Sims JL, Yeoh J, Stawell RJ. Acute retinal necrosis: a case series with clinical features and treatment outcomes. Clin Exp Ophthalmol. 2009;37(5):473\u20137. https:\/\/doi.org\/10.1111\/j.1442-9071.2009.02083.x.","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"417_CR32","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.ophtha.2006.08.037","volume":"114","author":"CH Lau","year":"2007","unstructured":"Lau CH, Missotten T, Salzmann J, et al. Acute retinal necrosis features, management, and outcomes. Ophthalmology. 2007;114(4):756\u201362. https:\/\/doi.org\/10.1016\/j.ophtha.2006.08.037.","journal-title":"Ophthalmology"},{"issue":"2","key":"417_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/1120672118787438","volume":"29","author":"DY Kim","year":"2019","unstructured":"Kim DY, Jo J, Joe SG, et al. Clinical feature and visual prognosis of acute retinal necrosis according to the initially involved zone and extent: 10-year experience. Eur J Ophthalmol. 2019;29(2):244\u201350. https:\/\/doi.org\/10.1177\/1120672118787438.","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"417_CR34","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.ophtha.2008.03.005","volume":"115","author":"Y Usui","year":"2008","unstructured":"Usui Y, Takeuchi M, Goto H, et al. Acute retinal necrosis in Japan. Ophthalmology. 2008;115(9):1632\u20133. https:\/\/doi.org\/10.1016\/j.ophtha.2008.03.005.","journal-title":"Ophthalmology"},{"issue":"5","key":"417_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/09273948.2014.925125","volume":"23","author":"S Khochtali","year":"2015","unstructured":"Khochtali S, Abroug N, Kahloun R, et al. Pattern of acute retinal necrosis in a referral center in Tunisia, North Africa. Ocul Immunol Inflamm. 2015;23(5):371\u20137. https:\/\/doi.org\/10.3109\/09273948.2014.925125.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"417_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2415-12-48","volume":"12","author":"SRJ Taylor","year":"2012","unstructured":"Taylor SRJ, Hamilton R, Hooper CY, et al. Valacyclovir in the treatment of acute retinal necrosis. BMC Ophthalmol. 2012;12(1):48. https:\/\/doi.org\/10.1186\/1471-2415-12-48.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"417_CR37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s0002-9343(99)00041-8","volume":"106","author":"MA Perazella","year":"1999","unstructured":"Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106(4):459\u201365. https:\/\/doi.org\/10.1016\/s0002-9343(99)00041-8.","journal-title":"Am J Med"},{"issue":"3","key":"417_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jcjo.2014.03.010","volume":"49","author":"H Choudhury","year":"2014","unstructured":"Choudhury H, Jindal A, Mithal K, et al. Intravitreal triamcinolone acetonide as an adjuvant in the management of acute retinal necrosis. Can J Ophthalmol. 2014;49(3):279\u201382. https:\/\/doi.org\/10.1016\/j.jcjo.2014.03.010.","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"417_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/iio.0000000000000077","volume":"55","author":"JG Shantha","year":"2015","unstructured":"Shantha JG, Weissman HM, Debiec MR, et al. Advances in the management of acute retinal necrosis. Int Ophthalmol Clin. 2015;55(3):1\u201313. https:\/\/doi.org\/10.1097\/iio.0000000000000077.","journal-title":"Int Ophthalmol Clin"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-022-00417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-022-00417-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-022-00417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T11:13:19Z","timestamp":1663240399000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-022-00417-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1186\/s40942-022-00417-w","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Mashhad University of Medical Sciences (Mashhad, Iran) approved the study protocol, which also adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from every patient on before reviewing the records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}